Dakovir-C 60 mg Tablet

৳ 400.00

Generic: Daclatasvir

Strength: 60 mg

Manufacturer: Beximco Pharmaceuticals Ltd..

Description

Indications

Daclatasvir is indicated in combination with Sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection in adults.

Dosage & Administration

The recommended dose of Daclatasvir is 60 mg once daily, to be taken orally with or without meals. Daclatasvir must be administered in combination with other medicinal products.

HCV-monoinfected or HCV/HIV coinfected patients with chronic hepatitis C without cirrhosis, including treatment-naïve patients and patients who failed on a treatment based on Peginterferon alfa & Ribavirin

  • All genotypes: Daclatasvir + Sofosbuvir for 12 weeks

HCV-monoinfected or HCV/HIV coinfected patients with chronic hepatitis C with compensated (Child-Pugh A) cirrhosis, including treatment-naïve patients and patients who failed on a treatment based on Peginterferon alfa & Ribavirin

  • Genotype 1,4,5,6: Daclatasvir + Sofosbuvir for 24 weeks or Daclatasvir + Sofosbuvir + Ribavirin for 12 weeks
  • Genotype 2: Daclatasvir + Sofosbuvir for 12 weeks
  • Genotype 3: Daclatasvir + Sofosbuvir + Ribavirin for 24 week

The dose of Ribavirin, when combined with Daclatasvir, is weight-based (1000 or 1200 mg in patients <75 kg or ≥75 kg, respectively).

* চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Reviews

There are no reviews yet.

Be the first to review “Dakovir-C 60 mg Tablet”